Pellegrino B - Search Results

1

Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers.

Tommasi C, Pellegrino B, Boggiani D, Sikokis A, Michiara M, Uliana V, Bortesi B, Bonatti F, Mozzoni P, Pinelli S, Squadrilli A, Viani MV, Cassi D, Maglietta G, Meleti M, Musolino A. Tommasi C, et al. Among authors: pellegrino b. Front Oncol. 2021 Sep 6;11:700853. doi: 10.3389/fonc.2021.700853. eCollection 2021. Front Oncol. 2021. PMID: 34552867 Free PMC article. Review.

2

Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers.

Musolino A, Boggiani D, Sikokis A, Rimanti A, Pellegrino B, Vattiato R, Sgargi P, Falcini F, Caminiti C, Michiara M, Leonardi F. Musolino A, et al. Among authors: pellegrino b. Cancer Treat Rev. 2016 Feb;43:1-7. doi: 10.1016/j.ctrv.2015.11.010. Epub 2015 Dec 7. Cancer Treat Rev. 2016. PMID: 26827687 Review.

3

Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.

Pellegrino B, Bella M, Michiara M, Zanelli P, Naldi N, Porzio R, Bortesi B, Boggiani D, Zanoni D, Camisa R, Neri TM, Pinto C, Musolino A. Pellegrino B, et al. Acta Biomed. 2016 May 6;87(1):54-63. Acta Biomed. 2016. PMID: 27163896

4

Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review.

Pellegrino B, Sikokis A, Bersanelli M, Leonetti A, Leonardi F, Di Meglio G, Buti S. Pellegrino B, et al. Gynecol Obstet Invest. 2016;81(5):385-93. doi: 10.1159/000446954. Epub 2016 Jun 17. Gynecol Obstet Invest. 2016. PMID: 27309542 Review.

5

Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient.

Pellegrino B, Musolino A, Tiseo M. Pellegrino B, et al. Ann Oncol. 2017 Jun 1;28(6):1405-1406. doi: 10.1093/annonc/mdx126. Ann Oncol. 2017. PMID: 28383638 Free article. No abstract available.

6

My best choice after a round trip from illness.

Tommasi C, Pellegrino B, Quaini F, Musolino A. Tommasi C, et al. Among authors: pellegrino b. Acta Biomed. 2017 Aug 23;88(2):196-197. doi: 10.23750/abm.v88i2.5777. Acta Biomed. 2017. PMID: 28845836 Free PMC article.

7

Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review.

Pellegrino B, Boggiani D, Tommasi C, Palli D, Musolino A. Pellegrino B, et al. Acta Biomed. 2017 Oct 23;88(3):329-333. doi: 10.23750/abm.v88i3.6138. Acta Biomed. 2017. PMID: 29083340 Free PMC article. Review.

8

Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study.

Musolino A, Falcini F, Sikokis A, Boggiani D, Rimanti A, Pellegrino B, Silini EM, Campanini N, Barbieri E, Zamagni C, Degli Esposti R, Cortesi L, Bisagni G, Cavanna L, Frassoldati A, Sgargi P, Michiara M. Musolino A, et al. Among authors: pellegrino b. Eur J Cancer. 2018 Jan;88:10-20. doi: 10.1016/j.ejca.2017.10.024. Epub 2017 Nov 23. Eur J Cancer. 2018. PMID: 29175735

9

Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review.

Pellegrino B, Musolino A, Llop-Guevara A, Serra V, De Silva P, Hlavata Z, Sangiolo D, Willard-Gallo K, Solinas C. Pellegrino B, et al. Transl Oncol. 2020 Feb;13(2):410-422. doi: 10.1016/j.tranon.2019.10.010. Epub 2020 Jan 2. Transl Oncol. 2020. PMID: 31901781 Free PMC article. Review.

10

Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis.

Pellegrino B, Mazzaschi G, Madeddu D, Mori C, Lagrasta CAM, Missale G, Quaini F, Musolino A. Pellegrino B, et al. Front Oncol. 2020 Feb 25;10:192. doi: 10.3389/fonc.2020.00192. eCollection 2020. Front Oncol. 2020. PMID: 32158689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page